Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vanda Pharmaceuticals Inc. (VNDA)  
$5.13 0.08 (1.58%) as of 4:30 Tue 5/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 61,398,000
Market Cap: 314.97(M)
Last Volume: 774,374 Avg Vol: 701,733
52 Week Range: $3.38 - $6.66
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  803
Guru Rank Value     : 1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 121,098 121,098 148,134 388,157
Total Sell Value $513,345 $513,345 $684,141 $2,735,436
Total People Sold 5 5 6 8
Total Sell Transactions 10 10 14 33
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 549
  Page 12 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baroldi Paolo SVP & Chief Medical Officer   •       –      –    2014-02-18 4 OE $0.00 $0 D/D 12,500 26,625     -
   Kelly James Patrick SVP, CFO, Sec & Treasurer   •       –      –    2014-02-18 4 D $13.46 $95,889 D/D (7,124) 41,223     -
   Kelly James Patrick SVP, CFO, Sec & Treasurer   •       –      –    2014-02-18 4 OE $0.00 $0 D/D 19,531 48,347     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2014-02-18 4 D $13.46 $239,211 D/D (17,772) 503,864     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2014-02-18 4 OE $0.00 $0 D/D 50,000 521,636     -
   Repella Robert SVP & Chief Commercial Officer   •       –      –    2013-11-21 4 S $12.12 $776,789 D/D (64,100) 15,000     -
   Repella Robert SVP & Chief Commercial Officer   •       –      –    2013-11-21 4 OE $3.12 $243,794 D/D 57,610 79,100     -
   Repella Robert SVP & Chief Commercial Officer   •       –      –    2013-11-20 4 S $11.89 $481,659 D/D (40,515) 21,490     -
   Repella Robert SVP & Chief Commercial Officer   •       –      –    2013-11-20 4 OE $5.90 $239,039 D/D 40,515 62,005     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2013-11-19 4 S $12.07 $107,784 D/D (8,928) 471,636     -
   Repella Robert SVP & Chief Commercial Officer   •       –      –    2013-11-19 4 S $12.07 $34,829 D/D (2,885) 21,490     -
   Kelly James Patrick SVP, CFO, Sec & Treasurer   •       –      –    2013-11-19 4 S $12.07 $40,421 D/D (3,348) 28,816     -
   Repella Robert SVP & Chief Commercial Officer   •       –      –    2013-07-29 4 OE $0.00 $0 D/D 9,375 24,375     -
   Kelly James Patrick SVP, CFO, Sec & Treasurer   •       –      –    2013-07-29 4 OE $0.00 $0 D/D 9,375 32,164     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2013-07-29 4 OE $0.00 $0 D/D 25,000 480,564     -
   Baroldi Paolo SVP & Chief Medical OfficerOff   •       –      –    2013-04-15 3 IO $0.00 $0 D/D 0 14,125     -
   Repella Robert SVP & Cheif Commercial Officer   •       –      –    2013-02-14 4 OE $0.00 $0 D/D 15,000 15,000     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2013-02-14 4 D $3.95 $66,502 D/D (16,836) 455,564     -
   Polymeropoulos Mihael Hristos President and CEO   •       •      –    2013-02-14 4 OE $0.00 $0 D/D 43,750 472,400     -
   Kelly James Patrick SVP, CFO, Sec & Treasurer   •       –      –    2013-02-14 4 D $3.95 $27,563 D/D (6,978) 22,789     -
   Kelly James Patrick SVP, CFO, Sec & Treasurer   •       –      –    2013-02-14 4 OE $0.00 $0 D/D 17,187 29,767     -
   Feeney John Joseph SVP & Chief Medical Officer   •       –      –    2012-02-16 4/A S $4.65 $22,152 D/D (4,760) 11,942     -
   Feeney John Joseph SVP & Chief Medical Officer   •       –      –    2012-02-16 4/A OE $0.00 $0 D/D 12,187 16,702     -
   Kelly James Patrick SVP, CFO, Sec & Treasurer   •       –      –    2012-02-16 4 S $4.67 $22,994 D/D (4,920) 12,580     -
   Kelly James Patrick SVP, CFO, Sec & Treasurer   •       –      –    2012-02-16 4 OE $0.00 $0 D/D 12,500 17,500     -
  549 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 12 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us